Gabriele Toietta
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.
Journal: Experimental hematology & oncology
Published: October 30, 2024
Dissecting human adipose tissue heterogeneity using single-cell omics technologies.
Journal: Stem cell research & therapy
Published: July 04, 2024
Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy.
Journal: Cancer innovation
Published: January 03, 2024
The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 02, 2024
Cancer immunity and immunotherapy beyond COVID-19.
Journal: Cancer immunology, immunotherapy : CII
Published: September 06, 2022
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
Journal: Cancers
Published: September 01, 2022
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
Journal: Life science alliance
Published: July 04, 2022
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.
Journal: Cancer immunology, immunotherapy : CII
Published: November 02, 2021
HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression.
Journal: Molecular cancer research : MCR
Published: August 04, 2021
Last Updated: 09/26/2026